ARCTURUS THERAPEUTICS, INC. COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • February 6th, 2018 • Payne Joseph E • Pharmaceutical preparations • California
This Common Stock Purchase Agreement (this “Agreement”) is made as of March 4, 2013 by and between Arcturus Therapeutics, Inc., a Delaware corporation (the “Company”), and Joseph E. Payne (“Purchaser”).
Lock-Up Agreement September 27, 2017Lock-Up Agreement • February 6th, 2018 • Payne Joseph E • Pharmaceutical preparations • Delaware
The undersigned (the “Shareholder”) understands that: (i) Alcobra Ltd., an Israeli company (“Alcobra”), has entered into an Agreement and Plan of Merger and Reorganization, dated as of September 27, 2017 (the “Merger Agreement”), with Arcturus Therapeutics, Inc., a Delaware corporation (“Arcturus”) and Aleph MergerSub, Inc., a Delaware corporation and wholly-owned subsidiary of Alcobra (“Merger Sub”), pursuant to which Merger Sub will be merged with and into Arcturus (the “Merger”) and the separate corporate existence of Merger Sub will cease and Arcturus will continue as the surviving corporation and (ii) in connection with the Merger, stockholders of Arcturus will receive shares of Alcobra Ordinary Shares (the “Merger Shares”). Capitalized terms used but not otherwise defined in this letter agreement will have the meanings ascribed to such terms in the Merger Agreement.
